Varicella ,Measless , Mumps

download Varicella ,Measless , Mumps

of 25

Transcript of Varicella ,Measless , Mumps

  • 8/13/2019 Varicella ,Measless , Mumps

    1/25

    Varicella ,measless ,

    mumpsEndemic desease

  • 8/13/2019 Varicella ,Measless , Mumps

    2/25

    Varicella

    Etiology :

    Transmitted via respiratory droplets and /

    or contact with lessions

    Infectious peroide begins 2 days before

    skin lession and ends when the lessions

    crust , usually 5 days later

    An episode of varicella confers immunocity

    , second episode are exceedingly rare

  • 8/13/2019 Varicella ,Measless , Mumps

    3/25

    Epidemiology

    Before varicella vaccine became widespread, 4million cases of chickenpox were reportedannually in the US , with 11.000 hospitalizationand 50100 deaths annualy

    Maximum incidence of varicella in children aged16 years

    Maximum transmission occurs during late winter

    and spring Highly contagius : secondary attack rate is 80

    100 % for contacts

  • 8/13/2019 Varicella ,Measless , Mumps

    4/25

    Sign and symptom

    Rash ussually start on the head and trunks andspreads to the rest of the body

    Varicellas hallmark is the simultaneouspresence of rash in different stages

    Each lesion starts as ared macula and passthrough stages of papula , vesicle ( pear ordewdrop on rose petal ), pustule, and thencrusts

    Other accompanying manifestasion includeheadache , malaise , anorexia , cough andcoryza , sore throat , and low grade fever

  • 8/13/2019 Varicella ,Measless , Mumps

    5/25

    Diagnosis

    Clinical diagnosis based on the

    characteristic appearance of the rash

    Tzanck smear of scrapping from the base

    of veisicles will show multinucleated giant

    cells

    Serologic test can be done to assess pior

    exposure to varicella but have little

    diagnostic value during acut infection

  • 8/13/2019 Varicella ,Measless , Mumps

    6/25

    Differential diagnosis

    Contact dermatitis

    Drug reaction

    Enterovirus

    Insect bites

    Impetigo

    Smallpox

    Urticaris

    Herpes simplex virus ( HSV )

  • 8/13/2019 Varicella ,Measless , Mumps

    7/25

    Treatment

    Symptomatic relief of fever and itching

    Do not use aspirin ( associated with Reyesyndrome )

    Antiviral ( acyclovir ) are used in some cases Progressive or severe varicella

    Life threatening complications ( e.g. Encephalitis ,pneumonia )

    Neonate or asolescent / adult patient ( because highrisk of severe desease )

    Patient with cancer or on steroid or otherimmunosuppresive therapies

  • 8/13/2019 Varicella ,Measless , Mumps

    8/25

    Universal vaccination with live virus has

    significantly reduced morbidity and

    mortality ; confers protection to 75100%

    of those immunizied ( children withimmunodeficiencies ( HIV , cancer ,

    steroid or other immunosuppressive

    regimen ) should not recive the varicellavaccine or any other live vaccine product

  • 8/13/2019 Varicella ,Measless , Mumps

    9/25

    Prognostic / Clinical course

    An other wise helthy child usually has 250500 lessions( but may have as few as 10 or as many as 1.500 )

    New lesions continue to erupt for 35 days

    Lessions usually crust within 1 week and heal completely

    by 2 weeks Contagius from 2 days before skin lessions appear until

    the lessionss crust

    Nearly 1 in 50 cases of varicella may be associated withcomplication ( i.e. Varicella pneumonia and encephalitis )

    Secondary bacterial infection may occur with invasivegroup A streptococcus, a serious infection thet mayenvolve rapidly into necrotizing fascitis or toxic shocksyndrome

  • 8/13/2019 Varicella ,Measless , Mumps

    10/25

    Measles

    Primary infection occurs in the respiratory epithelium ofthe nasopharynx

    After 23 days , viremia ensues with infection of thereticuloendothelial system

    A second viremia occurs 57 days after initial infection Rash develops about 14 days after initial exposure

    Highly contagius during both viremia periodsindividuals are also infectious 35 days before and up

    to 4 days after the rash Transmitted via respiratory droplets

  • 8/13/2019 Varicella ,Measless , Mumps

    11/25

    Epidemiology

    Typically occurs in prschool and young

    schoolaged children

    Occurs worldwide

    Peak incidence in late winter and spring

    >99% reduction of disease following

    childhood immunizationMost cases in US occur in individuals who

    recently entered the country

  • 8/13/2019 Varicella ,Measless , Mumps

    12/25

    Sign / symptoms

    Prodome Fever , coryza , hacking or brassy cough , non purulent

    conyungtivitis

    Koplik spots ( 1- mm bluewith spots, characteristicallyopposite lower premolas and oral mucosa )

    Exanthema phase Maculopapular eruption lasting 57 days ; typically begins on

    faced/ head and progress to nhand / feet

    Desquamation may occur

    Generalized lymphadenopathy

    Anorexia Diarrhea ( especially infant )

    Fever may persist 7- 10 days

  • 8/13/2019 Varicella ,Measless , Mumps

    13/25

    Diagnosis

    Primarily a clinical diagnosis : Kopliks spots arepathognomonic

    Lekopenia / lympophenia

    Elevated transaminases Serologigies are the most common methode for

    diagnosis A single measuremet of measles Ig M confirms the

    diagnosis; may be detected as earlty as the first dayof rash but may be falsely negative in 20 %

    Measurement of meales IgG helaps to distinguishacute infection from prior vaccination

  • 8/13/2019 Varicella ,Measless , Mumps

    14/25

    Differential Dx

    Enteroviral infection

    Parvoviral infection

    Rubella

    Rosola Kawasaki desease

    Toxic shock syndrome

    Rocky mountain spotted fever Drug reaction ( e g. Stevens Johnsons

    syndrome )

  • 8/13/2019 Varicella ,Measless , Mumps

    15/25

  • 8/13/2019 Varicella ,Measless , Mumps

    16/25

    Prevention with MMR vaccine is routinely

    given at 1215 mont and 4 - years of

    age ( vaccine failure after a single dose

    occurs in 25 % of children , however ,most cases will respond to the second

    dose )

  • 8/13/2019 Varicella ,Measless , Mumps

    17/25

    Prognosis / clinical course

    Complication are most common in children < age 5 or >age 20 ( 30% of cases have at least one complication )

    Acute otitis media ( 10 % ) , diarrhea ( 10 % )

    Lower respiratory tract infection, bacterial infection (5%):

    Bronkiolitis , bronkopneumonia, laryngotrakheobronkhitis, intersitial or lobar pneumonia

    Acute ensephalitis (0,1%): occurs 6 days after onset ofrash , may result in seizures and / or neurologis damage

    Subacute slerosing panencephalitis is a rare but fatalneurologis disese with progressive intelectualdeterioration , ataxia , seizures, and death : occurs anaverage of 7 years after meales infection

  • 8/13/2019 Varicella ,Measless , Mumps

    18/25

    Mumps

    A viral infection that primary result inparotitis

    Transmision via respiratory droplet

    Contagius 2 days before through 5 daysafter the onset of parotitis

    Incubation period of 2 weeks , average

    duration of illness 710 days Prior MMR vaccine , mumps was the

    greteast cause of aseptic meningitis

  • 8/13/2019 Varicella ,Measless , Mumps

    19/25

    Epidemiology

    Seasonal peaks in winter and spring butcan occur any time

    Peak incidence in children ages 59

    Fewer than 1.000 cases per year in USsince MMR vaccine was introduced

    Despite high immunization rates ,

    outbreaks of mumps still occur Permanent unilateral deafnes occur in 1 /

    20.000 persons

  • 8/13/2019 Varicella ,Measless , Mumps

    20/25

    Sign/ symptoms

    Prodome : myalgia , anorexia , malaise headeache, lowgrade fever , chill

    Patrotitis is the most common manifestasion (30-40%) Occurs within the first 2 days of illness , unilateral or bilateral

    involvement of parotid gland, salivary gland involment Manifest as ear pain

    Tender to palpation at angle of jaw, edema anterior to ear ,overlying skin is not erythematous ( as opposed to bacterialparotitis )

    Trismus may be prsent

    Asymptomatic in 20 %

  • 8/13/2019 Varicella ,Measless , Mumps

    21/25

    Diagnosis

    Primarly a clinical diagnosis

    Serologic assay are the most common

    methode of diagnosispresence of mump

    IgM alone confirm diagnosis , may be

    detected within first week of desease viral

    culture of urine , saliva , and /or CSF

    Labs may show lymphocytosis and

    increase amylase

  • 8/13/2019 Varicella ,Measless , Mumps

    22/25

    Differensial Dx

    Cytomegalovirus infection

    Entroviral infection

    Influenza infection

    Para influenza infection

    Parotis ductu obstruction

    Bacterial parotitis

    Tumor of salivary gland

    Mikulicz syndrome

  • 8/13/2019 Varicella ,Measless , Mumps

    23/25

    Treatment

    Supportive care

    MMR is alive vaccine thet confers life long

    immunity ;given in two doses at 1215

    month and then again at 46 years

  • 8/13/2019 Varicella ,Measless , Mumps

    24/25

    Prognosis / Clinical Course

    Menungoencephalitis is the most common complication Most cases are symptomatic

    Symptomatic meningitis occurs in 15 % of cases but generrallyresolves withour sequale

    In the pervaccin era , mumps was the most commoncause of aquired sensorineural hearing loss

    Orchitis is the most common complication in postpubertal males ( 50% ) , resulting in abrupt onset oftesticular swelling , pain , nause , vomiting , fever , and

    possible atrophy Oophoritis , pancreatitis , and myocardium may occur

    Increased severity of disease in adults

  • 8/13/2019 Varicella ,Measless , Mumps

    25/25

    Kepustakaan

    Buku kuliah 2 Ilmu kesehatan anak FK UI :

    Morbili ( campak,measles,Rubeola ) hal

    624

    Parotitis epidemika ( Gondong, Mumps)

    hal 629

    Varisela ( Cacar air, Chicken Pox ) hal

    637